Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

1.6K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved catalytic efficiency of P450 OleP for converting lithocholic acid into murideoxycholic and ursodeoxycholic acids through semi-rational and rational design.

Synthetic and systems biotechnology·2026
Same author

A bibliometric analysis of research trends and future directions in early detection of pancreatic cancer.

Discover oncology·2026
Same author

Discovery of selective CDK9 degraders with anti-AML activity using PROTAC technology.

Bioorganic chemistry·2026
Same author

An unexpected NH<sub>4</sub>HSO<sub>4</sub>-catalyzed C3-H alkenylation of quinoxalin-2(1<i>H</i>)-ones with allenes.

Chemical communications (Cambridge, England)·2026
Same author

Weakly-supervised deep learning on pathological whole-slide images for cutaneous vasculitis and its mimickers: a high-performance diagnostic support tool.

Scientific reports·2026
Same author

Antibiotic-Loaded Polymethyl Methacrylate Cement Drives Fibroblast-Mediated Angiogenesis via LOXL2 to Accelerate Diabetic Foot Ulcer Healing.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

Related Experiment Video

Updated: Jan 14, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.6K

Deep Learning for Drug-Target Interaction Prediction: A Comprehensive Review.

Yingjun Chen1, Ding Luo2, Weiwei Xue2

  • 1School of Computer and Information Engineering, Shanghai Polytechnic University, Shanghai, China.

Chemical Biology & Drug Design
|October 22, 2025
PubMed
Summary

Deep learning (DL) methods accelerate drug discovery by predicting drug-target interactions (DTIs). This review synthesizes DL approaches, datasets, and applications, addressing challenges and future directions for efficient DTI prediction.

Keywords:
DTI databasedeep learningdrug designdrug–target interaction predictionmachine learning

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K

Related Experiment Videos

Last Updated: Jan 14, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.6K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K

Area of Science:

  • Computational Biology
  • Pharmacology
  • Artificial Intelligence

Background:

  • Drug-target interaction (DTI) prediction is crucial for drug discovery but traditionally relies on slow experimental methods.
  • Deep learning (DL) offers a powerful and efficient alternative for predicting DTIs, accelerating the discovery pipeline.

Purpose of the Study:

  • To provide a structured overview of deep learning-based methods for drug-target interaction prediction.
  • To synthesize current advances, challenges, and future research directions in DL for DTI prediction.

Main Methods:

  • Review of feature representation strategies for drugs and proteins.
  • Analysis of various DL architectures: DNNs, RNNs, CNNs, GNNs, and Transformers.
  • Summary of common datasets and evaluation metrics for DTI prediction.

Main Results:

  • DL models demonstrate significant efficiency and power in predicting DTIs compared to traditional methods.
  • Exploration of DL applications in drug repositioning, drug design, and precision medicine.
  • Identification of key challenges including data scarcity and model interpretability.

Conclusions:

  • Deep learning is a transformative approach for DTI prediction, essential for modern drug discovery.
  • Future research should focus on self-supervised learning and explainable AI to overcome current limitations.
  • This review provides a comprehensive resource to guide future developments in DL-based DTI prediction.